This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58756735
rdf:type
wikibase:Item
schema:description
scholarly article published in Arthritis Research and Therapy im September 2018 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована у вересні 2018 article scientifique publié en 2018
p:P577
wds:Q58756735-5A93F2EE-9C37-4F63-8CC7-CC0A77E2382C
wdt:P577
2018-09-10T00:00:00Z
p:P407
wds:Q58756735-AEEC3415-478B-425E-9366-BD8CEE56A31A
wdt:P407
wd:Q1860
p:P2888
wds:Q58756735-28972F95-7FF0-44E7-9A62-085C082CFED1
wdt:P2888
n13:s13075-018-1700-2
p:P2860
wds:Q58756735-2C83E6A2-FB69-4EC7-A9A3-2D8845D08D28
wdt:P2860
wd:Q55346305
p:P2093
wds:Q58756735-D10696CB-C1C1-4853-A661-EAE45D93F134 wds:Q58756735-A3A50039-9006-41F9-B0C2-78C85CAAF806 wds:Q58756735-91893DC6-2C35-4A9D-A8B8-0414D637B2D8 wds:Q58756735-7258333E-CFC0-48D8-A5BC-6C60A9DBC4E6
wdt:P2093
Panagiota Drivelegka Mats Dehlin Valgerdur Sigurdardottir Anna Svärd
rdfs:label
Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
skos:prefLabel
Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
schema:name
Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
p:P50
wds:Q58756735-3EEA595E-70D0-4CB4-ACD0-45E477C78DDD
wdt:P50
wd:Q110625350
p:P1476
wds:Q58756735-F6876916-170D-4821-A28C-13784FD91EC5
wdt:P1476
Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
p:P304
wds:Q58756735-D2B6141B-7E29-4B04-A052-F013D1DD1842
wdt:P304
206
p:P31
wds:Q58756735-BBF2ABA0-DCEC-4447-B870-1D268EADC5CD wds:Q58756735-CB957FE8-8FC0-4EDF-A5A9-F2C8AC692725
wdt:P31
wd:Q13442814 wd:Q1348305
p:P921
wds:Q58756735-EA8C6F6E-5536-46BB-B5C1-74AD4E1D2925
wdt:P921
wd:Q1414874
p:P698
wds:Q58756735-F5C2ED1F-3C6B-4380-9979-5A9668BA2BAF
wdtn:P698
n10:30201030
wdt:P698
30201030
p:P1433
wds:Q58756735-E887E438-E10D-43D9-BB83-D89C24030DF7
wdt:P1433
wd:Q15757229
p:P433
wds:Q58756735-42E95D48-ED47-4995-9123-808996741721
p:P478
wds:Q58756735-7F9144E6-9235-473B-A6EB-C4C894805DDB
wdt:P433
1
wdt:P478
20
p:P356
wds:Q58756735-65A60468-3E8E-43FD-996E-3363F0C9A016
wdtn:P356
n12:S13075-018-1700-2
wdt:P356
10.1186/S13075-018-1700-2
p:P275
wds:Q58756735-61026a6a-f377-463d-96fc-df9f30b7d003
p:P6216
wds:Q58756735-5cd2b3f3-5acb-4344-8106-96b4e2430b71
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P6179
wds:Q58756735-DFD75A7D-A885-4F3A-9A02-66C3C5250F71
wdt:P6179
1106911912
p:P932
wds:Q58756735-3E6FCB09-91BE-40B3-859B-5B4F377788B0
wdt:P932
6130065